Tina Sugimoto, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sugimoto’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A60303 · Current
Licensed to practise in California · since 1996 · expires 2028-06-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$94,662
Medicare paid this office $94,662 for 246 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 180 | $29,399 | $103 |
| Long return visit (40+ min) | 90 | $26,438 | $153 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 114 | $17,916 | $157 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,230 | $291 |
| Short return visit (20+ min) | 37 | $2,470 | $62 |
See all 10 services
| Return visit (30+ min) | 180 | $29,399 | $103 |
| Long return visit (40+ min) | 90 | $26,438 | $153 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 114 | $17,916 | $157 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 18 | $5,230 | $291 |
| Short return visit (20+ min) | 37 | $2,470 | $62 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,187 | $199 |
| Influenza vaccine, inactivated | 21 | $1,718 | $82 |
| Administration of pneumococcal vaccine | 22 | $798 | $36 |
| Administration of influenza virus vaccine | 19 | $742 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 41 | $719 | $14 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
246 Original Medicare patients in 2024. Average age 75 · Women 68% · Also on Medicaid 5% · Health risk score 0.84. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 58% · Diabetes 27% · Chronic kidney disease 24% · Coronary heart disease 17% · Cancer 17% · Atrial fibrillation 11% · Depression 11% · Heart failure 10% · COPD 7% · Dementia 6% · Stroke 5%.
The office billed $270,384, Medicare allowed $123,979 and paid $94,662; for 841 services of 34 kinds; $8,434 of it was for drugs given in the office and $86,229 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 246 | 841 | 75 | 0.84 | $270,384 | $94,662 |
| 2023 | 250 | 1,093 | 76 | 0.86 | $240,067 | $90,571 |
| 2022 | 271 | 763 | 76 | 0.90 | $227,726 | $88,462 |
| 2021 | 232 | 704 | 75 | 0.88 | $209,621 | $80,650 |
| 2020 | 232 | 750 | 74 | 0.88 | $201,234 | $71,545 |
| 2019 | 241 | 1,430 | 75 | 0.90 | $216,000 | $77,181 |
| 2018 | 253 | 1,764 | 73 | 0.85 | $185,468 | $67,832 |
| 2017 | 157 | 420 | 74 | 0.78 | $94,753 | $34,325 |
| 2016 | 63 | 105 | 74 | 0.80 | $23,470 | $7,711 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 91 | $27,418 | $163 |
| Return visit (30+ min) | 163 | $24,674 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 122 | $19,464 | $160 |
| Short return visit (20+ min) | 64 | $4,203 | $63 |
| Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | 16 | $3,860 | $241 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 24 | $1,808 | $75 |
| Administration of influenza virus vaccine | 26 | $983 | $38 |
| Administration of pneumococcal vaccine | 22 | $772 | $35 |
2022: 9 services
| Return visit (30+ min) | 175 | $26,296 | $109 |
| Long return visit (40+ min) | 101 | $26,155 | $157 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 109 | $17,253 | $158 |
| Short return visit (20+ min) | 57 | $3,888 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,963 | $109 |
| Advance care planning, first 30 minutes | 21 | $1,490 | $71 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 16 | $1,124 | $70 |
| Administration of influenza virus vaccine | 22 | $834 | $38 |
| Administration of pneumococcal vaccine | 17 | $580 | $34 |
2021: 10 services
| Long return visit (40+ min) | 91 | $24,813 | $168 |
| Return visit (30+ min) | 133 | $20,717 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 98 | $14,272 | $146 |
| Short return visit (20+ min) | 56 | $4,476 | $71 |
| Advance care planning, first 30 minutes | 49 | $4,251 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,192 | $99 |
| Influenza vaccine split virus, preservative free | 12 | $783 | $65 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $561 | $31 |
| Short return visit | 13 | $396 | $30 |
| Administration of influenza virus vaccine | 13 | $284 | $22 |
2020: 10 services
| Return visit (30+ min) | 132 | $17,331 | $96 |
| Long return visit (40+ min) | 70 | $16,926 | $128 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 80 | $11,354 | $142 |
| Advance care planning, first 30 minutes | 66 | $6,000 | $90 |
| Short return visit (20+ min) | 87 | $5,677 | $59 |
| Pneumococcal vaccine, 23-valent | 18 | $2,111 | $117 |
| Influenza vaccine split virus, preservative free | 25 | $1,482 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,479 | $106 |
| Administration of influenza virus vaccine | 25 | $521 | $21 |
| Administration of pneumococcal vaccine | 24 | $499 | $21 |
2019: 12 services
| Return visit (30+ min) | 133 | $19,254 | $90 |
| Long return visit (40+ min) | 75 | $15,921 | $127 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 92 | $12,860 | $140 |
| Short return visit (20+ min) | 102 | $7,911 | $60 |
| Advance care planning, first 30 minutes | 45 | $4,289 | $95 |
| Pneumococcal vaccine, 13-valent | 15 | $3,115 | $208 |
| Pneumococcal vaccine, 23-valent | 27 | $2,990 | $111 |
| Influenza vaccine split virus, preservative free | 18 | $961 | $53 |
| Administration of pneumococcal vaccine | 41 | $841 | $21 |
| Short return visit | 24 | $709 | $30 |
| Administration of influenza virus vaccine | 19 | $390 | $21 |
| Automated urinalysis test | 11 | $32 | $2 |
2018: 11 services
| Return visit (30+ min) | 130 | $18,938 | $89 |
| Long return visit (40+ min) | 84 | $12,446 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 85 | $11,162 | $131 |
| Short return visit (20+ min) | 86 | $6,074 | $61 |
| Pneumococcal vaccine, 13-valent | 27 | $5,506 | $197 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,366 | $197 |
| Influenza vaccine split virus, preservative free | 34 | $1,472 | $43 |
| Pneumococcal vaccine, 23-valent | 11 | $1,161 | $106 |
| Short return visit | 34 | $1,061 | $29 |
| Administration of influenza virus vaccine | 37 | $952 | $26 |
| Administration of pneumococcal vaccine | 34 | $875 | $26 |
2017: 9 services
| Return visit (30+ min) | 83 | $11,204 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $4,332 | $127 |
| Pneumococcal vaccine, 13-valent | 20 | $3,742 | $187 |
| Short return visit (20+ min) | 55 | $3,664 | $58 |
| Long return visit (40+ min) | 21 | $3,310 | $132 |
| Short return visit | 26 | $1,011 | $36 |
| Influenza vaccine split virus, preservative free | 17 | $743 | $44 |
| Administration of pneumococcal vaccine | 23 | $699 | $30 |
| Administration of influenza virus vaccine | 19 | $612 | $32 |
2016: 2 services
| Return visit (30+ min) | 33 | $4,550 | $99 |
| Short return visit (20+ min) | 28 | $2,066 | $67 |
Drugs they prescribed that Part D paid
$140,917
Pharmacies billed $140,917 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,928 generic and fewer than 11 brand-name prescriptions · $140,917 in drug cost · 76 antibiotic prescriptions to 53 people · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 21 | $19,751 | $941 |
| Breo Ellipta | 12 | $4,631 | $386 |
| Atorvastatin | 264 | $2,145 | $8 |
| Amlodipine-Valsartan | 21 | $1,569 | $75 |
| Estradiol | 12 | $1,503 | $125 |
See all 50 drugs
| Ozempic | 21 | $19,751 | $941 |
| Breo Ellipta | 12 | $4,631 | $386 |
| Atorvastatin | 264 | $2,145 | $8 |
| Amlodipine-Valsartan | 21 | $1,569 | $75 |
| Estradiol | 12 | $1,503 | $125 |
| Amlodipine Besylate | 164 | $1,449 | $9 |
| Valacyclovir | 17 | $1,380 | $81 |
| Synthroid | 23 | $1,247 | $54 |
| Levothyroxine | 99 | $1,127 | $11 |
| Budesonide-Formoterol | 13 | $1,114 | $86 |
| Lisinopril | 96 | $991 | $10 |
| Fluticasone Propionate | 45 | $883 | $20 |
| Gabapentin | 32 | $881 | $28 |
| Pravastatin | 24 | $773 | $32 |
| Tamsulosin | 27 | $771 | $29 |
| Losartan | 70 | $606 | $9 |
| Metoprolol | 50 | $574 | $11 |
| Sertraline | 45 | $543 | $12 |
| Albuterol Sulfate Hfa | 22 | $495 | $23 |
| Trazodone | 55 | $490 | $9 |
| Metformin Hcl Er | 33 | $380 | $12 |
| Valsartan | 12 | $370 | $31 |
| Anastrozole | 13 | $368 | $28 |
| Metformin | 41 | $353 | $9 |
| Simvastatin | 23 | $349 | $15 |
| Famotidine | 21 | $322 | $15 |
| Escitalopram | 11 | $307 | $28 |
| Duloxetine | 14 | $286 | $20 |
| Losartan-Hydrochlorothiazide | 19 | $270 | $14 |
| Triamcinolone Acetonide | 23 | $265 | $12 |
| Clopidogrel | 27 | $254 | $9 |
| Triamterene-Hydrochlorothiazid | 16 | $202 | $13 |
| Minoxidil | 15 | $191 | $13 |
| Rosuvastatin | 13 | $181 | $14 |
| Butalbital-Acetaminophen-Caffe | 13 | $174 | $13 |
| Citalopram Hbr | 21 | $173 | $8 |
| Quetiapine | 15 | $171 | $11 |
| Omeprazole | 18 | $149 | $8 |
| Hydrochlorothiazide | 23 | $148 | $6 |
| Cephalexin | 17 | $141 | $8 |
| Amoxicillin-Clavulanate Potass | 15 | $131 | $9 |
| Clotrimazole | 19 | $123 | $6 |
| Metoprolol | 18 | $111 | $6 |
| Furosemide | 17 | $98 | $6 |
| Alendronate | 22 | $88 | $4 |
| Paroxetine | 12 | $79 | $7 |
| Lovastatin | 13 | $75 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $59 | $5 |
| Azithromycin | 16 | $45 | $3 |
| Fluoxetine | 21 | $41 | $2 |
Year by year
| 2024 | 2,147 | 276 | None | None | $140,917 |
| 2023 | 2,274 | 277 | None | None | $151,580 |
| 2022 | 2,243 | 281 | 1% (12) | None | $124,763 |
| 2021 | 2,210 | 241 | None | None | $116,736 |
| 2020 | 2,116 | 246 | None | None | $126,551 |
| 2019 | 2,173 | 239 | 1% (13) | 12% | $122,664 |
| 2018 | 1,445 | 217 | 2% (25) | 13% | $78,783 |
| 2017 | 413 | 113 | 4% (15) | None | $22,248 |
| 2016 | 64 | 33 | None | None | $2,795 |
| 2013 | 14 | None | 0% (0) | 0% | $246 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 58 drugs
| Synjardy | 20 | $22,186 | $1,109 |
| Eliquis | 15 | $13,806 | $920 |
| Breo Ellipta | 13 | $5,300 | $408 |
| Symbicort | 12 | $4,381 | $365 |
| Estradiol | 17 | $2,747 | $162 |
| Atorvastatin | 255 | $2,697 | $11 |
| Amlodipine-Valsartan | 19 | $1,957 | $103 |
| Synthroid | 22 | $1,852 | $84 |
| Amlodipine Besylate | 166 | $1,639 | $10 |
| Levothyroxine | 110 | $1,602 | $15 |
| Valacyclovir | 25 | $1,241 | $50 |
| Gabapentin | 58 | $1,229 | $21 |
| Losartan | 81 | $1,217 | $15 |
| Metoprolol | 63 | $927 | $15 |
| Pravastatin | 25 | $773 | $31 |
| Lisinopril | 80 | $739 | $9 |
| Metformin Hcl Er | 29 | $736 | $25 |
| Trazodone | 53 | $693 | $13 |
| Fluticasone Propionate | 34 | $626 | $18 |
| Potassium Chloride | 24 | $618 | $26 |
| Triamcinolone Acetonide | 20 | $613 | $31 |
| Sertraline | 51 | $601 | $12 |
| Tamsulosin | 29 | $566 | $20 |
| Albuterol Sulfate Hfa | 19 | $554 | $29 |
| Clopidogrel | 25 | $493 | $20 |
| Azelastine | 11 | $485 | $44 |
| Minoxidil | 18 | $478 | $27 |
| Simvastatin | 33 | $453 | $14 |
| Valsartan | 13 | $444 | $34 |
| Diltiazem 24hr Er (Cd) | 13 | $420 | $32 |
| Rosuvastatin | 23 | $398 | $17 |
| Metformin | 46 | $384 | $8 |
| Alendronate | 29 | $330 | $11 |
| Olmesartan Medoxomil | 11 | $323 | $29 |
| Duloxetine | 15 | $320 | $21 |
| Triamterene-Hydrochlorothiazid | 15 | $303 | $20 |
| Lisinopril-Hydrochlorothiazide | 20 | $300 | $15 |
| Escitalopram | 14 | $280 | $20 |
| Digoxin | 16 | $274 | $17 |
| Anastrozole | 14 | $271 | $19 |
| Famotidine | 23 | $269 | $12 |
| Hydrochlorothiazide | 30 | $263 | $9 |
| Donepezil | 14 | $225 | $16 |
| Omeprazole | 22 | $206 | $9 |
| Paroxetine | 13 | $200 | $15 |
| Nitrofurantoin Mono-Macro | 15 | $190 | $13 |
| Glimepiride | 11 | $190 | $17 |
| Celecoxib | 12 | $184 | $15 |
| Fluoxetine | 14 | $180 | $13 |
| Losartan-Hydrochlorothiazide | 17 | $162 | $10 |
| Amitriptyline | 11 | $142 | $13 |
| Citalopram Hbr | 19 | $137 | $7 |
| Azithromycin | 20 | $95 | $5 |
| Metoprolol | 18 | $85 | $5 |
| Furosemide | 20 | $85 | $4 |
| Lovastatin | 14 | $54 | $4 |
| Cephalexin | 14 | $52 | $4 |
| Cyclobenzaprine | 12 | $47 | $4 |
2022: 51 drugs
| Eliquis | 17 | $14,638 | $861 |
| Myrbetriq | 12 | $5,260 | $438 |
| Breo Ellipta | 11 | $4,324 | $393 |
| Estradiol | 20 | $2,896 | $145 |
| Atorvastatin | 235 | $2,601 | $11 |
| Synthroid | 20 | $2,397 | $120 |
| Levothyroxine | 111 | $2,162 | $19 |
| Metoprolol | 76 | $1,197 | $16 |
| Amlodipine Besylate | 147 | $1,106 | $8 |
| Gabapentin | 49 | $923 | $19 |
| Cyclobenzaprine | 11 | $849 | $77 |
| Losartan | 69 | $789 | $11 |
| Lisinopril | 95 | $730 | $8 |
| Fluticasone Propionate | 47 | $661 | $14 |
| Simvastatin | 38 | $575 | $15 |
| Omeprazole | 53 | $573 | $11 |
| Sertraline | 48 | $569 | $12 |
| Valacyclovir | 13 | $564 | $43 |
| Metformin Hcl Er | 35 | $559 | $16 |
| Trazodone | 36 | $537 | $15 |
| Metformin | 46 | $525 | $11 |
| Tamsulosin | 27 | $510 | $19 |
| Triamterene-Hydrochlorothiazid | 26 | $508 | $20 |
| Fluoxetine | 25 | $473 | $19 |
| Duloxetine | 23 | $431 | $19 |
| Pantoprazole | 13 | $399 | $31 |
| Diltiazem 24hr Er (Cd) | 14 | $390 | $28 |
| Venlafaxine Hcl Er | 11 | $389 | $35 |
| Escitalopram | 17 | $383 | $23 |
| Potassium Chloride | 21 | $363 | $17 |
| Pravastatin | 17 | $361 | $21 |
| Celecoxib | 15 | $319 | $21 |
| Atenolol | 16 | $297 | $19 |
| Donepezil | 16 | $292 | $18 |
| Nitrofurantoin Mono-Macro | 16 | $267 | $17 |
| Diclofenac | 11 | $250 | $23 |
| Alendronate | 33 | $242 | $7 |
| Clopidogrel | 15 | $241 | $16 |
| Allopurinol | 13 | $223 | $17 |
| Triamcinolone Acetonide | 17 | $220 | $13 |
| Rosuvastatin | 13 | $214 | $16 |
| Hydrochlorothiazide | 34 | $177 | $5 |
| Lovastatin | 12 | $167 | $14 |
| Furosemide | 26 | $147 | $6 |
| Cephalexin | 17 | $132 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $124 | $7 |
| Famotidine | 13 | $120 | $9 |
| Losartan-Hydrochlorothiazide | 13 | $107 | $8 |
| Citalopram Hbr | 19 | $98 | $5 |
| Azithromycin | 11 | $53 | $5 |
| Warfarin | 12 | $43 | $4 |
2021: 49 drugs
| Jardiance | 12 | $8,186 | $682 |
| Breo Ellipta | 12 | $4,335 | $361 |
| Estradiol | 28 | $3,507 | $125 |
| Atorvastatin | 229 | $2,950 | $13 |
| Levothyroxine | 114 | $2,376 | $21 |
| Synthroid | 15 | $1,948 | $130 |
| Metoprolol | 79 | $1,770 | $22 |
| Losartan | 69 | $1,563 | $23 |
| Venlafaxine Hcl Er | 20 | $1,012 | $51 |
| Amlodipine Besylate | 138 | $983 | $7 |
| Trazodone | 55 | $856 | $16 |
| Pantoprazole | 21 | $789 | $38 |
| Gabapentin | 38 | $745 | $20 |
| Sertraline | 33 | $735 | $22 |
| Omeprazole | 46 | $671 | $15 |
| Lisinopril | 93 | $649 | $7 |
| Fluticasone Propionate | 47 | $648 | $14 |
| Duloxetine | 36 | $596 | $17 |
| Albuterol Sulfate Hfa | 13 | $584 | $45 |
| Simvastatin | 55 | $578 | $11 |
| Metformin Hcl Er | 44 | $551 | $13 |
| Triamterene-Hydrochlorothiazid | 30 | $545 | $18 |
| Metformin | 57 | $540 | $9 |
| Escitalopram | 15 | $464 | $31 |
| Alendronate | 45 | $455 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $432 | $36 |
| Cyclobenzaprine | 12 | $426 | $36 |
| Potassium Chloride | 14 | $401 | $29 |
| Tamsulosin | 13 | $342 | $26 |
| Pravastatin | 19 | $304 | $16 |
| Rosuvastatin | 19 | $286 | $15 |
| Clopidogrel | 17 | $248 | $15 |
| Fluoxetine | 18 | $245 | $14 |
| Nitrofurantoin Mono-Macro | 20 | $239 | $12 |
| Brimonidine | 13 | $227 | $17 |
| Donepezil | 16 | $211 | $13 |
| Furosemide | 29 | $198 | $7 |
| Rizatriptan | 12 | $195 | $16 |
| Klor-Con 8 | 17 | $193 | $11 |
| Lisinopril-Hydrochlorothiazide | 24 | $192 | $8 |
| Allopurinol | 11 | $181 | $16 |
| Atenolol | 15 | $172 | $11 |
| Citalopram Hbr | 18 | $148 | $8 |
| Glimepiride | 16 | $147 | $9 |
| Lovastatin | 12 | $146 | $12 |
| Hydrochlorothiazide | 24 | $111 | $5 |
| Triamcinolone Acetonide | 13 | $75 | $6 |
| Zolpidem | 11 | $69 | $6 |
| Warfarin | 13 | $36 | $3 |
2020: 46 drugs
| Anoro Ellipta | 13 | $5,765 | $443 |
| Estradiol | 25 | $5,261 | $210 |
| Breo Ellipta | 14 | $4,908 | $351 |
| Atorvastatin | 181 | $3,407 | $19 |
| Levothyroxine | 112 | $3,256 | $29 |
| Losartan-Hydrochlorothiazide | 12 | $2,359 | $197 |
| Metoprolol | 75 | $2,251 | $30 |
| Shingrix | 11 | $1,798 | $163 |
| Synthroid | 14 | $1,332 | $95 |
| Venlafaxine Hcl Er | 44 | $1,161 | $26 |
| Trazodone | 55 | $1,046 | $19 |
| Gabapentin | 42 | $1,014 | $24 |
| Losartan | 68 | $997 | $15 |
| Diltiazem 24hr Er (Cd) | 23 | $956 | $42 |
| Rosuvastatin | 23 | $883 | $38 |
| Fluticasone Propionate | 25 | $750 | $30 |
| Amlodipine Besylate | 101 | $731 | $7 |
| Levoxyl | 16 | $688 | $43 |
| Omeprazole | 51 | $625 | $12 |
| Lisinopril | 90 | $618 | $7 |
| Sertraline | 28 | $602 | $21 |
| Triamterene-Hydrochlorothiazid | 27 | $560 | $21 |
| Simvastatin | 58 | $544 | $9 |
| Duloxetine | 23 | $509 | $22 |
| Escitalopram | 18 | $486 | $27 |
| Donepezil | 21 | $474 | $23 |
| Potassium Chloride | 23 | $472 | $21 |
| Metformin | 50 | $466 | $9 |
| Cyclobenzaprine | 16 | $423 | $26 |
| Pramipexole Dihydrochloride | 12 | $393 | $33 |
| Clopidogrel | 15 | $392 | $26 |
| Allopurinol | 14 | $379 | $27 |
| Metformin Hcl Er | 23 | $355 | $15 |
| Hydrochlorothiazide | 40 | $341 | $9 |
| Alendronate | 36 | $337 | $9 |
| Lovastatin | 13 | $324 | $25 |
| Pravastatin | 15 | $321 | $21 |
| Atenolol | 21 | $276 | $13 |
| Fluoxetine | 12 | $227 | $19 |
| Lisinopril-Hydrochlorothiazide | 21 | $225 | $11 |
| Furosemide | 35 | $190 | $5 |
| Rizatriptan | 11 | $183 | $17 |
| Citalopram Hbr | 17 | $164 | $10 |
| Tizanidine | 11 | $113 | $10 |
| Azithromycin | 13 | $107 | $8 |
| Amitriptyline | 12 | $59 | $5 |
2019: 50 drugs
| Breo Ellipta | 13 | $4,412 | $339 |
| Atorvastatin | 149 | $3,577 | $24 |
| Wixela Inhub | 13 | $2,765 | $213 |
| Levothyroxine | 91 | $2,599 | $29 |
| Shingrix | 12 | $2,151 | $179 |
| Metoprolol | 65 | $1,838 | $28 |
| Estradiol | 15 | $1,828 | $122 |
| Synthroid | 19 | $1,825 | $96 |
| Venlafaxine Hcl Er | 36 | $1,295 | $36 |
| Gabapentin | 56 | $1,251 | $22 |
| Oxybutynin Chloride Er | 19 | $1,004 | $53 |
| Trazodone | 46 | $878 | $19 |
| Diltiazem 24hr Er (Cd) | 16 | $848 | $53 |
| Losartan | 67 | $824 | $12 |
| Bupropion Xl | 14 | $811 | $58 |
| Valacyclovir | 15 | $792 | $53 |
| Triamterene-Hydrochlorothiazid | 37 | $759 | $21 |
| Rosuvastatin | 14 | $747 | $53 |
| Metformin Hcl Er | 36 | $698 | $19 |
| Amlodipine Besylate | 96 | $693 | $7 |
| Fluticasone Propionate | 44 | $641 | $15 |
| Omeprazole | 43 | $637 | $15 |
| Simvastatin | 68 | $613 | $9 |
| Pramipexole Dihydrochloride | 12 | $610 | $51 |
| Butalbital-Aspirin-Caffeine | 12 | $588 | $49 |
| Sertraline | 40 | $568 | $14 |
| Pantoprazole | 13 | $557 | $43 |
| Lisinopril | 74 | $556 | $8 |
| Potassium Chloride | 20 | $527 | $26 |
| Metformin | 42 | $524 | $12 |
| Alendronate | 34 | $493 | $14 |
| Celecoxib | 17 | $458 | $27 |
| Hydrochlorothiazide | 53 | $445 | $8 |
| Duloxetine | 14 | $403 | $29 |
| Lisinopril-Hydrochlorothiazide | 27 | $367 | $14 |
| Cyclobenzaprine | 17 | $353 | $21 |
| Lovastatin | 15 | $266 | $18 |
| Ranitidine | 11 | $264 | $24 |
| Nitrofurantoin Mono-Macro | 15 | $234 | $16 |
| Donepezil | 15 | $224 | $15 |
| Amitriptyline | 13 | $209 | $16 |
| Warfarin | 11 | $190 | $17 |
| Azithromycin | 28 | $187 | $7 |
| Latanoprost | 11 | $181 | $16 |
| Triamcinolone Acetonide | 13 | $180 | $14 |
| Rizatriptan | 12 | $179 | $15 |
| Atenolol | 16 | $177 | $11 |
| Fluoxetine | 13 | $166 | $13 |
| Furosemide | 28 | $163 | $6 |
| Losartan-Hydrochlorothiazide | 11 | $59 | $5 |
2018: 33 drugs
| Aripiprazole | 11 | $2,851 | $259 |
| Atorvastatin | 102 | $2,642 | $26 |
| Levothyroxine | 81 | $2,184 | $27 |
| Metoprolol | 41 | $1,695 | $41 |
| Synthroid | 16 | $1,451 | $91 |
| Oxybutynin Chloride Er | 22 | $1,112 | $51 |
| Bupropion Xl | 14 | $720 | $51 |
| Gabapentin | 28 | $714 | $26 |
| Omeprazole | 28 | $698 | $25 |
| Venlafaxine Hcl Er | 19 | $563 | $30 |
| Cyclobenzaprine | 11 | $551 | $50 |
| Losartan | 44 | $540 | $12 |
| Fluticasone Propionate | 21 | $519 | $25 |
| Metformin | 31 | $473 | $15 |
| Trazodone | 28 | $433 | $15 |
| Triamterene-Hydrochlorothiazid | 18 | $409 | $23 |
| Amlodipine Besylate | 54 | $398 | $7 |
| Simvastatin | 38 | $387 | $10 |
| Alendronate | 27 | $327 | $12 |
| Rosuvastatin | 11 | $312 | $28 |
| Sertraline | 25 | $285 | $11 |
| Lisinopril | 43 | $285 | $7 |
| Hydrochlorothiazide | 29 | $282 | $10 |
| Atenolol | 16 | $260 | $16 |
| Ranitidine | 11 | $250 | $23 |
| Nitrofurantoin Mono-Macro | 16 | $247 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $235 | $18 |
| Metformin Hcl Er | 19 | $192 | $10 |
| Donepezil | 12 | $180 | $15 |
| Azithromycin | 18 | $102 | $6 |
| Zolpidem | 14 | $97 | $7 |
| Olanzapine | 11 | $93 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $59 | $5 |
2017: 7 drugs
| Metoprolol | 16 | $757 | $47 |
| Atorvastatin | 22 | $421 | $19 |
| Levothyroxine | 11 | $256 | $23 |
| Omeprazole | 11 | $112 | $10 |
| Amlodipine Besylate | 19 | $112 | $6 |
| Metformin | 16 | $103 | $6 |
| Zolpidem | 11 | $55 | $5 |
Money from drug and device companies
$434 in 2025
| 2025 | 5 | 5 | None | $434 |
| 2019 | 1 | 1 | None | $131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Freestyle Libre 3 | $141 | 1 payment
|
| Lilly USA | Kisunla | $117 | 1 payment
|
| Novo Nordisk | Ozempic | $102 | 1 payment
|
| Abbvie | Mavyret | $59 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Wainua | $15 | 1 payment
|
See all 5 published payments
| Abbott Laboratories | Meals · 2025-10-30 | Freestyle Libre 3 | $141 |
| Lilly USA | Meals · 2025-09-17 | Kisunla | $117 |
| Novo Nordisk | Meals · 2025-09-06 | Ozempic | $102 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-08 | Wainua | $15 |
| Abbvie | Meals · 2025-08-06 | Mavyret | $59 |
See earlier years (2019)
2019: $131
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $131 | 1 payment
|
Professional record
- NPI
- 1295832335
- Licence
- CA A60303California A60303: Current · expires 2028-06-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-09-20
- NPI last updated
- 2016-10-07
This is when the NPI record was last certified, not a medical board exam.